| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.85B | -44.7% |
| Cost of Revenue | $4.49B | -43.1% |
| R&D Expense | $193.0M | -63.7% |
| SG&A Expense | $1.02B | -34.3% |
| Interest Expense | $313.0M | -14.5% |
| Pre-tax Income | $200.0M | -83.2% |
| Income Tax | $102.0M | -75.4% |
| Net Income | -$779.0M | -210.8% |
| EPS (Basic) | -$1.87 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $715.0M | -61.4% |
| Accounts Receivable | $910.0M | -40.7% |
| Inventory | $1.17B | -45.0% |
| Current Assets | $5.58B | -12.4% |
| Total Assets | $21.57B | -41.1% |
| Current Liabilities | $2.31B | -52.0% |
| Long-term Debt | $3.13B | -41.1% |
| -211.3% |
| EPS (Diluted) | -$1.86 | -211.4% |
| Total Liabilities |
| $7.47B |
| -41.8% |
| Stockholders' Equity | $13.92B | -40.4% |